Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOMBOLA: Atezolizumab for Biochemical Relapse of Bladder Cancer
NCT04138628Phase 2Active, not recruiting
- Start
- Mar 2020
- Primary completion
- Aug 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in bladder cancer. Started Mar 2020; status: active, not recruiting.
02
Drugs
atezolizumab
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04138628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04138628.